Want to join the conversation?
$PKI's human health business represented about 61% of reported revenue in 3Q15 with diagnostics contributing 28% of revenue and research 33% of revenue. Organic revenue growth from the company's diagnostic business increased high single digits, driven by continued strength in its newborn screening franchise.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)